Follow us on
Welcome Guest! You are here: Home » Health
'Popular anti-epileptic drug could lead to birth defects'
Sunday October 20, 2013 6:58 PM, IANS

Anti-epileptic drug valproate (VPA) should not be used by women of child-bearing age as it could have harmful effects on the baby, a British expert Sunday said.

Valproic acid is used worldwide as an anti-convulsant (seizure prevention) and studies in the Britain, Ireland, US, and Europe have shown it could have potential birth (teratogenic) effects.

"There is a lot of evidence that show VPA has teratogenic effects. It can significantly impact children's cognitive development and has higher risk of impairment. The most important message would be to avoid the drug in women of child-bearing age and in pregnant women," said Peter Newman, fellow of London's Royal College of Physicians (RCP).

He was speaking at the "Medicon International 2013" organised by RCP in collaboration with Peerless Hospital and B.K.Roy Foundation, Kolkata.

Around 50 million people in the world have epilepsy. Close to 80 percent of epilepsy cases worldwide are found in developing regions.

Newman spoke in favour of using cheaper drugs "as efficacy is similar and tolerability only a little less when compared to older and new AEDs".

.



Share this page
 Comments
Note: By posting your comments here you agree to the terms and conditions of www.ummid.com
comments powered by Disqus
Advertisement
| Quick links
About ummid.com
Contact us
Feedback
Subscribe to: RSS » Facebook » Twitter » Newsletter
Ummid.com: Disclaimer | Terms of Use | Advertise with us | Link Exchange
Ummid.com is part of the Awaz Multimedia & Publications providing World News, News Analysis and Feature Articles on Education, Health. Politics, Technology, Sports, Entertainment, Industry etc. The articles or the views displayed on this website are for public information and in no way describe the editorial views. The users are entitled to use this site subject to the terms and conditions mentioned.
© 2012 Awaz Multimedia & Publications. All rights reserved.